3 hours Regeneron Pharmaceuticals (NASDAQ:REGN) PT Lowered to $1,137.00 at Truist FinancialMarketBeat
Truist Financial reduced their target price on shares of Regeneron Pharmaceuticals from $1,200.00 to $1,137.00 and set a “buy” rating on the stock in a research report on Wednesday.
Nasdaq 100 · Pharmaceuticals · Regeneron Pharma (REGN) · Science · Truist Financial Corp (TFC)
X